Exploratory study about the influence of drug administration guidance on patients satisfaction with treatment after administration of Mirogabalin - MiroSearch

akashima Hiroaki0 个研究点目标入组 200 人开始时间: 2023年7月13日最近更新: 2024年5月27日

试验速览

暂无简介。

•1. Patients diagnosed with neuropathic pain due to orthopedic disorders
•2. First patient treated with a neuropathic pain medication
•3. Patients who are scheduled to continue treatment for at least 8 weeks and are able to attend the relevant medical institution
•4. Patients aged 18 years or older at the time of obtaining informed consent
•5. Patients who can understand the procedure of this study, answer questions in Japanese appropriately in writing and by electromagnetic means (ePRO) without assistance, and give their own written consent on their own free will to participate in this study by writing or electromagnetic means (eConsent)

•1. Patients who are considered to require inpatient treatment at the time of study entry
•2. Patients scheduled to undergo surgery during the study period
•3. Patients with severe pain attributable to a disease other than the relevant disease and considered difficult to evaluate.
•4. Patients with creatinine clearance (CLcr) <30 mL/min
•5. Patients with complicated serious liver, kidney, and heart disease
•6. Patients who are pregnant or possibly pregnant at the time of obtaining informed consent, patients who are breastfeeding at the time of obtaining informed consent, and patients who intend to become pregnant within 6 months after obtaining informed consent
•7. Patients participating in or planned to participate in other intervention studies at enrollment
•8. Other patients judged by the principal investigator or subinvestigator to be ineligible for participation in this study

发起方

akashima Hiroaki